Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance

OBJECTIVE: The goal of this study was to monitor imatinib mesylate therapeutically in the Tumor Biology Laboratory, Department of Hematology and Hemotherapy, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (USP). A simple and sensitive method to quantify imatinib and its meta...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rezende, Vinícius Marcondes, Rivellis, Ariane Julio, Gomes, Melissa Medrano, Dörr, Felipe Augusto, Novaes, Mafalda Megumi Yoshinaga, Nardinelli, Luciana, Costa, Ariel Lais de Lima, Chamone, Dalton de Alencar Fisher, Bendit, Israel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Associação Brasileira de Hematologia e Hemoterapia 2013
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3672119/
https://ncbi.nlm.nih.gov/pubmed/23741187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5581/1516-8484.20130030
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller